A detailed history of Verition Fund Management LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 39,916 shares of CELC stock, worth $508,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,916
Previous 165,675 75.91%
Holding current value
$508,130
Previous $2.71 Million 78.07%
% of portfolio
0.0%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.98 - $19.15 $1.76 Million - $2.41 Million
-125,759 Reduced 75.91%
39,916 $595,000
Q2 2024

Aug 14, 2024

SELL
$14.1 - $20.78 $2.51 Million - $3.71 Million
-178,309 Reduced 51.84%
165,675 $2.71 Million
Q1 2024

May 14, 2024

BUY
$13.74 - $21.6 $4.73 Million - $7.43 Million
343,984 New
343,984 $7.43 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $190M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.